tiger accelerator logo square_edited.jpg

Dr. Steve Roffler

Pavilion:
National Biotechnology Research Park (BioTReC research group)
Industry:
Cancer Treatment, Nanomedicines

About

The glycosidic switch liposome (GSL) platform increases the power of nanomedicines by facilitating active loading, stable retention and safe delivery of drugs in liposomes.